These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5006772)

  • 21. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly with 'normal' growth hormone levels.
    Feingold KR; Lorenz TJ
    West J Med; 1985 Jan; 142(1):95-7. PubMed ID: 3976225
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of acromegaly with bromocryptine.
    Summers VK; Hipkin LJ; Diver MH; Davis JC
    J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suppression of blood growth hormone level by somatostatin infusion in patients with active acromegaly.
    Kwok CF; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):249-54. PubMed ID: 2907415
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis of acromegaly].
    Althoff PH; Rau H; Schmidt K; Usadel KH
    Dtsch Med Wochenschr; 1991 Jun; 116(24):941-4. PubMed ID: 2044462
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of single doses of indomethacin and aspirin on the serum growth hormone concentration in acromegaly].
    Pawlikowski M; Owczarczyk I
    Endokrynol Pol; 1981; 32(4):315-8. PubMed ID: 7308171
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acromegaly. I. Diagnostic use of radioimmunological determination of the somatotropic hormone].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(24):745-50. PubMed ID: 4714502
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitory effect of dopaminergic stimulation on GH release in acromegaly.
    Chiodini PG; Liuzzi A; Botalla L; Cremascoli G; Silvestrini F
    J Clin Endocrinol Metab; 1974 Feb; 38(2):200-6. PubMed ID: 4812616
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum insulin and growth hormone during glucose loading in liver cirrhosis].
    Schatz H; Paumgartner G; Brunner H; Höfer R; Grabner G
    Wien Z Inn Med; 1971; 52(1):41-6. PubMed ID: 5540818
    [No Abstract]   [Full Text] [Related]  

  • 36. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.